Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn.

This position reports to the SVP, Head of Cell Therapy and is part of the Cell Therapy team within the Technology and Quality organization which leads the development and manufacturing of Regenerative medicine portfolio within SMPA. The role is responsible for leading and providing strategic alignment and direction within SMPA Process and Analytical Development Cell Therapy group, and works closely with CPC based ...